Browsing by Subject "echocardiography"
Now showing items 1-2 of 2
-
(2022-03-15)Department: Biomedical EngineeringIn 2017 the sclerostin targeting monoclonal antibody Romosozumab was approved as a treatment for post-menopausal osteoporosis (PMO) despite cardiovascular side effects discovered in clinical trials. Previous studies indicated ...
-
(Journal of the American Heart Association, 2019-09-23)Background-Identification of occult diastolic dysfunction often requires invasive right heart catheterization with provocative maneuvers such as fluid challenge. Non-invasive predictors of occult diastolic dysfunction have ...